ASIC and ASX may be reading this article and asking themselves a few questions. http://www.smh.com.au/business/emba...hed-the-corporations-act-20150802-gipmhn.html
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%